The invention relates to a pharmaceutical composition comprising a pyrrole derivative of the following formula [1] or a pharmaceutically acceptable salt thereof, or a solvate of either of them, as an active ingredient. ##STR1## (wherein R.sup.1 represents hydrogen or alkoxycar91 bonylamino, R.sup.2 represents alkyl, aryl which may be substituted, aromatic heterocyclyl which may be substituted, unsubstituted amino, monoalkylamino, dialkylamino, or cyclic amino which may be substituted; R.sup.3 represents cyano or carbamoyl; R.sup.4 represents hydrogen or alkyl; E represents alkylene; q is equal to 0 or 1, A represents methyl, aryl which may be substituted, or aromatic heterocyclyl which may be substituted). The pharmaceutical composition of the invention is effective for the treatment of pollakiuria or urinary incontinence.
该发明涉及一种药物组合物,其包括以下式[1]的
吡咯衍
生物或其药学上可接受的盐,或者它们中的任何一个的溶剂化合物,作为活性成分。##STR1##(其中R.sup.1代表氢或烷氧羰基
氨基,R.sup.2代表烷基,芳基(可能被取代),芳香杂环基(可能被取代),未取代的
氨基,单烷基
氨基,二烷基
氨基,或者可能被取代的环
氨基;R.sup.3代表
氰基或者
氨基甲酰基;R.sup.4代表氢或者烷基;E代表烷基;q等于0或1,A代表甲基,芳基(可能被取代),或者芳香杂环基(可能被取代)。该发明的药物组合物对于治疗尿频或尿失禁有效。